Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancers
worldwide. More than half of patients with HNSCC eventually experience disease …

Immunogenic cell death (ICD) is a regulated cell death (RCD) pathway. In response to
physical and chemical signals, tumor cells activate specific signaling pathways that stimulate …

Abstract Programmed cell death 1 (PD-1) blockade therapy can result in dramatic responses
in some patients with cancer. However, about 15% of patients receiving PD-1 blockade …

Simple Summary Near-infrared photoimmunotherapy (NIR-PIT) represents a potential novel
treatment modality for a range of cancer types, including head and neck cancers. NIR-PIT is …

Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer treatment
modality based on a target-specific photosensitizer conjugate (TSPC) composed of an NIR …

Simple Summary Head and neck photoimmunotherapy (HN-PIT) is a new treatment
developed for local control of head and neck carcinoma. This study assessed the quality of …

The potential of photoactivating certain molecules, photosensitizers (PS), resulting in
photochemical processes, has long been realized in the form of photodynamic therapy …

Simple Summary Near-infrared photoimmunotherapy (NIR-PIT) is a novel molecularly-
targeted therapy that induces rapid cancer cell death by systemically administering an …

Disialoganglioside (GD2) is a subtype of glycolipids that is highly expressed in tumors of
neuroectodermal origins, such as neuroblastoma and osteosarcoma. Its limited expression …

Photodynamic therapy (PDT) research would benefit from an automated, low-cost, and easy-
to-use cell culture light treatment setup capable of illuminating multiple well replicates within …